Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?

Jimenez R, Zhang B, Joffe S, Nilsson M, Rivera L, Mutchler J, Lathan C, Paulk ME, Prigerson HG.

J Palliat Med. 2013 Mar;16(3):256-62. doi: 10.1089/jpm.2012.0413. Epub 2013 Feb 5.

2.

Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Murthy VH, Krumholz HM, Gross CP.

JAMA. 2004 Jun 9;291(22):2720-6.

PMID:
15187053
3.

The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?

Shone LP, Dick AW, Brach C, Kimminau KS, LaClair BJ, Shenkman EA, Col JF, Schaffer VA, Mulvihill F, Szilagyi PG, Klein JD, VanLandeghem K, Bronstein J.

Pediatrics. 2003 Dec;112(6 Pt 2):e521.

PMID:
14654674
4.

Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.

Enzinger AC, Zhang B, Weeks JC, Prigerson HG.

J Pain Symptom Manage. 2014 Jun;47(6):1078-90. doi: 10.1016/j.jpainsymman.2013.07.004. Epub 2013 Oct 5.

5.

Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina.

Zullig LL, Fortune-Britt AG, Rao S, Tyree SD, Godley PA, Carpenter WR.

N C Med J. 2016 Jan-Feb;77(1):52-8. doi: 10.18043/ncm.77.1.52.

6.

Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life.

Balboni TA, Balboni M, Enzinger AC, Gallivan K, Paulk ME, Wright A, Steinhauser K, VanderWeele TJ, Prigerson HG.

JAMA Intern Med. 2013 Jun 24;173(12):1109-17. doi: 10.1001/jamainternmed.2013.903.

7.

Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.

Brooks SE, Carter RL, Plaxe SC, Basen-Engquist KM, Rodriguez M, Kauderer J, Walker JL, Myers TK, Drake JG, Havrilesky LJ, Van Le L, Landrum LM, Brown CL.

Gynecol Oncol. 2015 Jul;138(1):101-8. doi: 10.1016/j.ygyno.2015.04.033. Epub 2015 Apr 30.

8.

Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.

Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP.

Ann Surg Oncol. 2007 Dec;14(12):3328-34. Epub 2007 Aug 8.

PMID:
17682824
9.

Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.

Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL, Jackson VA, Block SD, Maciejewski PK, Prigerson HG.

JAMA. 2008 Oct 8;300(14):1665-73. doi: 10.1001/jama.300.14.1665.

10.

Coaching intervention as a strategy for minority recruitment to cancer clinical trials.

Fracasso PM, Goodner SA, Creekmore AN, Morgan HP, Foster DM, Hardmon AA, Engel SJ, Springer BC, Mathews KJ, Fisher EB, Walker MS.

J Oncol Pract. 2013 Nov;9(6):294-9. doi: 10.1200/JOP.2013.000982. Epub 2013 Oct 15.

11.

Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences.

Smith AK, McCarthy EP, Paulk E, Balboni TA, Maciejewski PK, Block SD, Prigerson HG.

J Clin Oncol. 2008 Sep 1;26(25):4131-7. doi: 10.1200/JCO.2007.14.8452.

12.

Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.

Langford AT, Resnicow K, Dimond EP, Denicoff AM, Germain DS, McCaskill-Stevens W, Enos RA, Carrigan A, Wilkinson K, Go RS.

Cancer. 2014 Mar 15;120(6):877-84. doi: 10.1002/cncr.28483. Epub 2013 Dec 10.

13.

Enrollment of patients with lung and colorectal cancers onto clinical trials.

Fouad MN, Lee JY, Catalano PJ, Vogt TM, Zafar SY, West DW, Simon C, Klabunde CN, Kahn KL, Weeks JC, Kiefe CI.

J Oncol Pract. 2013 Mar;9(2):e40-7. doi: 10.1200/JOP.2012.000598.

14.

Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.

Penberthy L, Brown R, Wilson-Genderson M, Dahman B, Ginder G, Siminoff LA.

Clin Trials. 2012 Dec;9(6):788-97. doi: 10.1177/1740774512458992. Epub 2012 Oct 2.

15.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

16.

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.

17.

Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer.

Phelps AC, Maciejewski PK, Nilsson M, Balboni TA, Wright AA, Paulk ME, Trice E, Schrag D, Peteet JR, Block SD, Prigerson HG.

JAMA. 2009 Mar 18;301(11):1140-7. doi: 10.1001/jama.2009.341.

18.

Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.

Aristizabal P, Singer J, Cooper R, Wells KJ, Nodora J, Milburn M, Gahagan S, Schiff DE, Martinez ME.

Pediatr Blood Cancer. 2015 Aug;62(8):1337-44. doi: 10.1002/pbc.25472. Epub 2015 Mar 8.

PMID:
25755225
19.

End-of-life treatment preferences: a key to reducing ethnic/racial disparities in advance care planning?

Garrido MM, Harrington ST, Prigerson HG.

Cancer. 2014 Dec 15;120(24):3981-6. doi: 10.1002/cncr.28970. Epub 2014 Aug 21.

20.

Family income and the impact of a children's health insurance program on reported need for health services and unmet health need.

Feinberg E, Swartz K, Zaslavsky A, Gardner J, Walker DK.

Pediatrics. 2002 Feb;109(2):E29.

PMID:
11826239
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk